SCHEMBL9307305

SCHEMBL9307305

ClC=CC#CCOc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.44
KCNA3 P22001 1/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 2/20 0.35
TAAR1 Q96RJ0 1/20 0.35
RECQL P46063 1/20 0.35
AOC3 Q16853 1/20 0.35
ALOX15 P16050 1/20 0.34
THRB P10828 1/20 0.34
EGFR P00533 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
LTA4H P09960 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9307301 1.00 KCNH2 (0.44) KCNH2KCNA3CA12CA1CA2
SCHEMBL9307406 0.80 KCNH2 (0.42) KCNH2KCNA3CA12CA1CA2
SCHEMBL9307399 0.80 KCNH2 (0.42) KCNH2KCNA3CA12CA1CA2
SCHEMBL9808291 0.77 KCNH2 (0.57) KCNH2KCNA3CA12CA1CA2
SCHEMBL9306972 0.76 KCNH2 (0.46) KCNH2KCNA3CA12CA1CA2
SCHEMBL9306983 0.76 KCNH2 (0.46) KCNH2KCNA3CA12CA1CA2
SCHEMBL10571938 0.74 KCNH2 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL10246513 0.74 KCNH2 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL1790840 0.73 KCNH2 (0.53) KCNH2KCNA3CA12CA1CA2
SCHEMBL7501197 0.72 KCNH2 (0.49) KCNH2KCNA3CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5318989-A Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-07 US disclosed
EP-0538898-A2 Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof Bristol-Myers Squibb Company (US) 1993-04-28 EP disclosed
US-5198560-A Antitumor agents based on esperamicin antibiotics BRISTOL-MYERS SQUIBB COMPANY (US) 1993-03-30 US disclosed